• Platform
  • Pipeline
    • Overview
    • Clinical Trial
  • Team
    • Leadership
    • Board of Directors
  • News
  • Careers

BioWorld: Keeping it simple: Kelonia raises a $50M series A 

by brian@orrbitt.com | May 2, 2022 | News

Kelonia: redirecting in vivo gene therapy

by brian@orrbitt.com | Apr 28, 2022 | News

Kelonia Scores $50M to Propel In Vivo Gene Delivery Platform

by brian@orrbitt.com | Apr 28, 2022 | News

Gene therapy outfit emerges from stealth with big ambitions. First stop — CAR-T

by brian@orrbitt.com | Apr 28, 2022 | News

Kelonia Therapeutics Launches with $50 Million Series A Financing to Pioneer Precision Targeted Genetic Medicines

by brian@orrbitt.com | Apr 28, 2022 | Press Releases

In Vivo Gene Delivery Platform Will Dramatically Expand the Benefit and Reach of Genetic Medicines Founded and Led by Leading Experts in Immunology, Oncology, and Cell and Gene Therapy Strategic Collaborations with Leading Industry Partners Enable and Accelerate...

Recent Posts

  • Kelonia Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for KLN-1010, an in vivo BCMA CAR-T Therapy for Relapsed and Refractory Multiple Myeloma   
  • Kelonia Therapeutics Presents First-in-Human Data from Phase 1 inMMyCAR Study of KLN-1010 in vivo BCMA CAR-T Therapy at the American Society of Hematology (ASH) 2025 Annual Meeting  
  • Kelonia Therapeutics Announces Late-Breaking Oral Presentation of First-in-Human Data from in vivo BCMA CAR-T Therapy at the American Society of Hematology (ASH) 2025 Annual Meeting
  • Kelonia Therapeutics Enters into Strategic Collaboration with Johnson & Johnson to Advance in vivo CAR-T Therapies
  • Kelonia Therapeutics Doses First Patient in Phase 1 inMMyCAR Study Evaluating in vivo CAR T-Cell Therapy for Relapsed and Refractory Multiple Myeloma

Recent Comments

No comments to show.

Genetic Medicines for Every Patient.

  • Platform
  • Pipeline
    • Overview
    • Clinical Trial
  • Team
    • Leadership
    • Board of Directors
  • News
  • Careers




© 2025 KELONIA THERAPEUTICS, INC. ALL RIGHTS RESERVED.
PRIVACY POLICY. TERMS OF USE